For the Inventor, By the Inventor

Enter assignee name

Meiji Seika Kabushiki Kaisha

USPTO Granted Patents = 32

EPO Patents = 1

Forward Citations = 245

Loading Chart...

Loading Chart...

112 inventors (with patents filed for the assignee):

Kiyoaki Katano (8 out of 24 patents)

Kunio Atsumi (7 out of 32 patents)

Takashi Tsuruoka (7 out of 52 patents)

4. Eiki Shitara (6 out of 17 patents)

5. Katsuyoshi Iwamatsu (6 out of 33 patents)

6. Seiji Shibahara (6 out of 44 patents)

7. Hiroko Ogino (6 out of 12 patents)

8. Tomoaki Miura (5 out of 12 patents)

9. Tomoya Machinami (5 out of 9 patents)

10. Shokichi Ohuchi (5 out of 7 patents)

11. Mami Kawaguchi (4 out of 8 patents)

12. Shigeharu Inouye (4 out of 49 patents)

13. Atsushi Tamura (4 out of 14 patents)

14. Fumiya Hirano (3 out of 10 patents)

15. Yoshimasa Fukuda (3 out of 10 patents)

32 patents: Sort by Forward Citations

1. 7138263 - Endoglucanase enzyme NCE5 and cellulase preparations containing the same (2006-11-21),

2. 6419972 - Starch-base puffed snack foods and process for producing the same (2002-07-16),

3. 5990101 - Carbapenem derivatives (1999-11-23),

4. 5958981 - .gamma.-diketone compounds with inhibitory activity against platelet (1999-09-28),

5. 5883089 - Cephem derivatives (1999-03-16),

6. 5840895 - Triazole intermediates for tricyclic benzazepine and benzothiazepine (1998-11-24),

7. 5814636 - Compounds with platelet aggregation inhibitor activity (1998-09-29),

8. 5786387 - Lipid double-chain derivative containing polyoxyethylene (1998-07-28),

9. 5760053 - .gamma.-Diketone compounds with inhibitory activity against platelet (1998-06-02),

10. 5698692 - Compound with platelet aggregation inhibitor activity (1997-12-16),

11. 5686442 - Tricyclic benzazepine and benzothiazepine derivatives (1997-11-11),

12. 5663162 - Cephem derivatives (1997-09-02),

13. 5661144 - Cephem derivatives with 3-substituted bis heterocycles (1997-08-26),

14. 5599815 - Antipsychotic benzoisothiazolyl piperazine derivatives (1997-02-04),

15. 5594004 - Compound with platelet aggregation inhibitor activity (1997-01-14),

Meiji Seika Kabushiki Kaisha is a Japanese pharmaceutical company headquartered in Tokyo, Japan. Founded in 1916, Meiji Seika focuses on manufacturing and marketing of pharmaceutical and healthcare products. Their product portfolio includes prescription drugs, over-the-counter medications, and nutritional supplements. Meiji Seika is committed to improving people's health and well-being through innovative research and development. For more information, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

32 Patents

#903 in Tokyo

#2,184 in Japan

#20,074 in the World

Meiji Seika Kabushiki Kaisha

Forward Citations = 245

112 inventors:

Kiyoaki Katano (8 out of 24 patents)

Kunio Atsumi (7 out of 32 patents)

Takashi Tsuruoka (7 out of 52 patents)

4. Eiki Shitara (6 out of 17 patents)

5. Katsuyoshi Iwamatsu (6 out of 33 patents)

Please report any incorrect information to support@idiyas.com

Loading…